THANK YOU FOR REGISTERING
FOR THE APELLIS GA SYMPOSIUM

SIGN UP TO STAY CONNECTED

Fill out the form below to receive updates about GA from Apellis.

All fields required.

First Name Enter your first name

Last Name Enter your last name

Email Enter your Email address

ZIP Enter your ZIP

Select your specialty

By submitting this form, I authorize Apellis Pharmaceuticals, Inc., its affiliates and their representatives, agents, contractors and companies working with Apellis (collectively, “Apellis”), to contact me by mail, email, telephone, and text messages for marketing purposes or to otherwise provide me with information about Apellis products, services, and programs or other topics of interest; conduct market research; or otherwise ask me about my experience with or thoughts about such topics. I understand and agree that any information that I provide may be used by Apellis to help develop new products, services, and programs. I understand that I may revoke this authorization and choose not to receive information from Apellis by clicking the “unsubscribe” link provided in emails I receive from Apellis or by emailing Apellis at info@apellis.com. I have read and understand the Privacy Policy.

You are leaving pre-lesion.com

The site you are linking to is not controlled by Apellis, and we are not responsible for its content.

Are you sure you want to leave?

YES

CANCEL

Apellis Geographic Atrophy (GA) Symposium: Register Now

Required fields denoted by an asterisk (*) You must be a US healthcare professional to register.

Title *

Enter title

Full Name *

Enter your first name

Enter your last name

Suffix *

Select your suffix

Specialty *

Select your specialty

Professional designation *

Select your specialty

NPI number *

Enter your NPI numner

Affiliation *

Enter your affiliation

Address

Email *

Enter your Email address

Phone Number

I authorize Apellis Pharmaceuticals, Inc., its affiliates and their representatives, agents, contractors and companies working with Apellis (collectively, “Apellis”), to contact me by mail, email, telephone, and text messages for marketing purposes or to otherwise provide me with information about Apellis products, services, and programs or other topics of interest; conduct market research; or otherwise ask me about my experience with or thoughts about such topics. I understand and agree that any information that I provide may be used by Apellis to help develop new products, services, and programs. I understand that I may revoke this authorization and choose not to receive information from Apellis by clicking the “unsubscribe” link provided in emails I receive from Apellis or by emailing Apellis at info@apellis.com. I have read and understand the Privacy Policy.

thank you for registering

References

1. Boyer DS, et al. Retina. 2017;37:819-835.
2. Park DH, et al. Front Immunol. 2019;10:1007.
3. Yates JRW, et al. N Engl J Med. 2007;357(6):553-561.
4. Katschke KJ Jr, et al. Sci Rep. 2018;8(1):13055.
5. Lindblad AS, et al, and AREDS Research Group. Arch Ophthalmol. 2009;127(9):1168-1174
6. Holz FG, et al. Ophthalmology. 2014;121(5):1079-1091.
7. Sunness JS, et al. Ophthalmology. 2007;114(2):271-277.
8. Van Lookeren Campagne M, et al. J Pathol. 2014;232:151-164.
9. Gehrs KM, et al. Ann Med. 2006;38(7):450-471.
10. Chakravarthy U, et al. Ophthalmol Retina. 2020;4(7):662-672.
11. Xu L, et al. Retina. 2015;35(2):176-186.
12. Rofagha S, et al, SEVEN-UP Study Group. Ophthalmology. 2013;120(11):2292-2299.
13. Sadda SR, et al. Ophthalmology. 2018;125(6):878-886.
14. Rahimy E. Presented at: American Academy of Ophthalmology Meeting; November 13-15, 2020; virtual.
15. Sunness JS, et al. Ophthalmology. 1997;104(10):1677-1691.
16. Sunness JS, et al. Ophthalmology. 1996;103:1458-1466.
17. Sunness JS, et al. Am J Ophthalmol. 2005;140:1085-1093.
18. Sivaprasad S, et al. Ophthalmol Ther. 2019;8:115-124.
19. Singh RP, et al. Am J Ophthalmic Clin Trials. 2019. https://ajoclinicaltrials.com/patient-caregiver-and-eye-care-professional-reported-burden-of-geographic-atrophy-secondary-to-age-related-macular-degeneration/
20. Friedman DS, et al, Eye Diseases Prevalence Research Group. Arch Ophthalmol. 2004;122:564-572.
21. Chakravarthy U, et al. Ophthalmology. 2018;125:842-849.
22. Merle NS, et al. Front Immunol. 2015;6:262.
23. Smailhodzic D, et al. Ophthalmology. 2012;119(2):339-346.
24. Mastellos DC, et al. Trends Immunol. 2017;38(6):383-394.
25. Ricklin D, et al. Immunol Rev. 2016;274(1):33-58.
26. Heesterbeek TJ, et al. Invest Ophthalmol Vis Sci. 2020;61(3):18.
27. Seddon JM, et al. Nat Genet. 2013;45:1366-1370.
28. Patel PJ, et al. Clin Ophthalmol. 2020;14:15-28.
29. Fleckenstein M, et al. Ophthalmology. 2018;125:369-390.
30. Bradley DT, et al. Eye. 2011;25:683-693.
31. Liao DS, et al. Retinal Physician. 2019. www.retinalphysician.com/issues/2019/november-2019/inhibiting-complement-c3-in-dry-amd

Are you a
US HEALTHCARE PROFESSIONAL?